Health ❯ Healthcare

Medications

Weight Loss Weight Loss Drugs Side Effects GLP-1 Drugs Weight Management Diabetes Diabetes Medications Weight Loss Medications GLP-1 Agonists Prescription Drugs

Medicare GLP-1 Use Surges as CMS Advances Coverage Expansion and Lilly Eyes Q2 Pill Launch

Lower copays plus a new coverage pathway could make GLP-1 treatments more affordable for many seniors.

Serena Williams Leads Ro’s Super Bowl GLP-1 Campaign, Citing Major Health Gains

CMS Names 15 Drugs for 2028 Medicare Price Talks, First List to Include Part B Treatments

Randomized Trial Finds Solriamfetol Improves Alertness in Early-Morning Shift Workers

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Gabrielle Union Reframes Menopause, Promotes Awareness of Newly Approved Hot-Flash Treatment

NICE Endorses Dupilumab as First Targeted Biologic for Uncontrolled Eosinophilic COPD

The Beauty Debuts on FX, Hulu and Disney+ With Big Buzz and Divided Reviews

Amanda Bynes Debuts 'Trap Star' Hand Tattoo in Hollywood After Recent Ozempic Weight-Loss Reveal

Wegovy Pill Debuts to Strong U.S. Demand as Next‑Gen Obesity Drugs Near Decisions

New Evidence Flags Rapid Weight Regain After Stopping GLP-1 Drugs

Bariatric Surgery’s Long-Term Edge Holds Across Social Vulnerability, ARMMS-T2D Analysis Finds

Trump Cites 'Very Fat' Friend's Ozempic Story to Decry Price Gap

Wegovy Pill Posts Strong U.S. Debut as U.K. Authorizes Higher 7.2 mg Injectable Dose

FDA Seeks Removal of Suicide Warnings From Saxenda, Wegovy and Zepbound

JAMA Study Finds 1 in 4 Medicare Patients With Dementia Receive Risky CNS-Active Drugs

BMJ Review Flags Rapid Weight Regain After GLP‑1 Stop as UK Approves Higher‑Dose Wegovy

Tom Brady Joins eMed as Founding Chief Wellness Officer and Board Member

Trump Says He Hasn’t Taken GLP-1 Weight-Loss Drugs, ‘Probably Should’

Novo Nordisk Launches Wegovy Weight‑Loss Pill in U.S. at $149 Starter Price